Therapeutic advances in reproductive health

Ther Adv Reprod Health · ISSN (e) 2633-4941 · 5 papers in corpus
article 2024
doi:10.1177/26334941241242351 ·PMID:38618559

BACKGROUND: To date, there remains a paucity of present-day literature on the topic of demographics and the biopsy-proven pathological positivity rate of endometriosis. OBJECTIVE: The goal of this study was to explore the association betwe…

other 2024
doi:10.1177/26334941241227401 ·PMID:38283750

BACKGROUND: Medical management of adenomyosis is an emerging perspective in modern gynecology. Though levonorgestrel intrauterine system (LNG-IUS) and dienogest (DNG) effectively relieve symptoms in adenomyosis, neither has been approved fo…

review 2024
doi:10.1177/26334941241277759 ·PMID:39376635

Endometriosis is a prevalent gynecological disease, leading to chronic pain and inflammation, affecting 1 in 10 individuals presumed female at birth. The diagnostic journey is often arduous, marked by neglect of the right diagnosis and prol…

article 2023
doi:10.1177/26334941231181258 ·PMID:37362235

Background: Currently, there is some evidence that adenomyosis patients using gonadotropin-releasing hormone (GnRH) agonist long downregulation (LDR) prior to embryo transfer may improve in vitro fertilization (IVF) success rate, but not to…

review 2020
doi:10.1177/2633494120964517 ·PMID:33294846

While the most common symptom associated with endometriosis is pelvic pain, the systemic manifestations of the disease and the accompanying adverse psychological, emotional, social, familial, sexual, educational and workplace effects are in…